Hong Kong stock anomaly | GEMSTONE-302 long-term survival data of cornerstone Pharmaceuticals-B (02616.HK) increased by more than 5% published in "The Lancet Oncology" again

According to the Securities Times app, CSPC Pharmaceutical Group Limited-B (02616.HK) has risen by more than 5%. As of press time, it has increased by 5.08%, reaching HK$4.14, with a turnover of 10.91 million Hong Kong dollars.